ArticleScientific reports2025
Sonophotocatalytic efficiency of nickel and copper supported ferrite nanoparticles doped MWCNTs nanocatalyst as a novel catalyst for amoxicillin degradation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The main objective of this study was to evaluate the potential for amoxicillin (AMX) degradation in a sonophotocatalytic system employing a nickel-copper supported ferrite nanoparticle-doped MWCNTs nanocatalyst (NCFM). Our target catalyst was prepared based on the coprecipitation method, and its synthesis was verified by undergoing various techniques, including FTIR, XRD, FESEM/EDX, BET, and TEM. Best results in terms of AMX, COD, and TOC removal efficiencies were recognized in the optimum values of the parameters so that their removal efficiencies were 100%, 95%, and 93%, respectively. The observed optimum values were 25 mg. L⁻¹ AMX, pH of 3, photocatalyst mass of 0.6 g.L⁻¹, time of 40 min, ultrasonic wave frequency of 35 kHz, and UV intensity of 24 W. According to kinetic studies, the sonophotcatalytic process in the presence of NCFM was found to be more successful in degrading AMX compared to other assessed processes, i.e., sonolysis, photolysis, photocatalysis, and sonocatalysis. Moreover, hydroxyl radical (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.